- Country: TAIWAN
- Official Title: 主治醫師
- Department: 臺中榮民總醫院血液腫瘤科
Speech Title
Current Myeloma Treatment in Taiwan
Multiple myeloma (MM) treatment in Taiwan has evolved significantly with the introduction of novel therapies. This presentation provides an overview of current treatment strategies, including the use of proteasome inhibitors, immunomodulatory drugs, and monoclonal antibodies. Advances in autologous stem cell transplantation (ASCT) and the incorporation of combination regimens have further improved patient outcomes. Additionally, ongoing clinical trials and the increasing availability of CAR-T cell therapies represent the future of MM care. This talk will highlight the challenges and opportunities in optimizing MM treatment within Taiwan’s healthcare system.